Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

10X Genomics Inc (TXG)

  • Business News
  • Nov. 18, 2025, 14:05 UTC
  • 5
  • 0 comments

10x Genomics - New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics Xenium

Market reaction Comment Full text

Nexalin Technology Inc (NXLIW)

  • Business News
  • Nov. 18, 2025, 14:00 UTC
  • 8
  • 0 comments

Nexalins 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity

Market reaction Comment Full text

Sonnet BioTherapeutics Holdings Inc. (SONN)

  • Business News
  • Nov. 18, 2025, 14:00 UTC
  • 8
  • 0 comments

Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting

Market reaction Comment Full text

Allurion Technologies Inc (ALUR)

  • Business News
  • Nov. 18, 2025, 14:00 UTC
  • 8
  • 0 comments

Allurion - Allurion Announces Strategic Distribution Partnership with ProSurg Medical in Brazil to Pioneer New Approach Focused on Metabolically Healthy Weight Loss

Market reaction Comment Full text

Nexalin Technology Inc (NXLIW)

  • Business News
  • Nov. 18, 2025, 14:00 UTC
  • 18
  • 1 comments

Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity

Market reaction Comment Full text

BullFrog AI Holdings Inc Unit (BFRG)

  • Business News
  • Nov. 18, 2025, 14:00 UTC
  • 7
  • 0 comments

BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights

Market reaction Comment Full text

10X Genomics Inc (TXG)

  • Business News
  • Nov. 18, 2025, 14:00 UTC
  • 16
  • 1 comments

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics Xenium

Market reaction Comment Full text

Clearmind Medicine Inc (CMND)

  • Business News
  • Nov. 18, 2025, 13:56 UTC
  • 17
  • 1 comments

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Market reaction Comment Full text

AIM ImmunoTech Inc. (AIM)

  • Business News
  • Nov. 18, 2025, 13:55 UTC
  • 23
  • 1 comments

AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program

Market reaction Comment Full text

Halozyme Therapeutics Inc (HALO)

  • Business News
  • Nov. 18, 2025, 13:50 UTC
  • 11
  • 0 comments

Halozyme - Halozyme Completes Acquisition of Elektrofi, Expanding Breadth of Offerings in Drug Delivery

Market reaction Comment Full text
  • Previous
  • 572
  • 573
  • 574
  • 575
  • 576
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191986)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125295)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin